Yilong Ai Selected Research

Immunotherapy

10/2023	Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages.
12/2021	Repression of CRNDE enhances the anti-tumour activity of CD8 + T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3.
1/2021	LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilong Ai Research Topics

Disease

13	Squamous Cell Carcinoma of Head and Neck 02/2024 - 01/2020
12	Neoplasms (Cancer) 12/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2021
3	Mouth Neoplasms (Oral Cancer) 09/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2022
2	Wounds and Injuries (Trauma) 10/2022 - 09/2022
2	Carcinogenesis 01/2021 - 01/2021
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Epstein-Barr Virus Infections 03/2023
1	Inflammation (Inflammations) 01/2023
1	Periodontal Diseases (Periodontal Disease) 01/2023
1	Fibrosis (Cirrhosis) 05/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Colitis 01/2022
1	ATR-X syndrome 12/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Bone Resorption 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Disease Progression 11/2020

Drug/Important Bio-Agent (IBA)

6	Circular RNAIBA 10/2023 - 11/2020
4	Long Noncoding RNAIBA 01/2022 - 01/2020
3	Arecoline (Arecolin)IBA 09/2022 - 01/2021
3	N-methyladenosineIBA 09/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	CateninsIBA 01/2023 - 01/2020
2	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 09/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2021
1	Annexin A5IBA 12/2023
1	AntigensIBA 12/2023
1	EnzymesIBA 12/2023
1	ImmunosorbentsIBA 12/2023
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2023
1	Propidium (Propidium Iodide)IBA 12/2023
1	Messenger RNA (mRNA)IBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	Leukocyte Immunoglobulin-like Receptor B1IBA 03/2023
1	Fibroins (Fibroin)IBA 01/2023
1	HydrogelsIBA 01/2023
1	CurcuminIBA 01/2023
1	Alkaline PhosphataseIBA 09/2022
1	Sincalide FDA Link 09/2022
1	Alizarin Red SIBA 09/2022
1	LigandsIBA 09/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Acetates (Acetic Acid Esters)FDA Link 01/2022
1	(1-6)-alpha-glucomannan (glucomannan)IBA 01/2022
1	protein 460IBA 12/2021
1	lactobionic acid (lactobionate)IBA 03/2021
1	ThymineIBA 03/2021
1	Methotrexate (Mexate)FDA LinkGeneric 03/2021
1	ChitosanIBA 03/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	CarcinogensIBA 01/2021
1	6-methyladenineIBA 01/2021
1	InterleukinsIBA 01/2021
1	AlkaloidsIBA 01/2021

Therapy/Procedure

4	Therapeutics 12/2023 - 01/2021
3	Immunotherapy 10/2023 - 01/2021
1	Intraperitoneal Injections 12/2023